Diet and prostate cancer risk in a cohort of smokers, with a specific focus on calcium and phosphorus (Finland)

Cancer Causes and Control

Volumn 11, Issue 9, 2000, Pages 859-867

  Chan, J M ^a   Pietinen, P ^a   Virtanen, M ^a   Malila, N ^a   Tangrea, J ^a   Albanes, D ^a   Virtamo, J ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Calcium; Diet; Fructose; Phosphorus; Prostate cancer

Indexed keywords

ALPHA TOCOPHEROL; BETA CAROTENE; CALCITRIOL; CALCIUM; FRUCTOSE; PHOSPHORUS; PLACEBO; PROTEIN;

ADULT; AGE; AGED; ARTICLE; BODY MASS; CALORIC INTAKE; CANCER RISK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DIETARY INTAKE; DOUBLE BLIND PROCEDURE; EDUCATION; FINLAND; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROSTATE CANCER; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SMOKING;

AGE FACTORS; AGED; BODY MASS INDEX; CALCIUM; CALCIUM, DIETARY; DIETARY CARBOHYDRATES; DIETARY PROTEINS; DOUBLE-BLIND METHOD; FINLAND; FRUCTOSE; HUMANS; MALE; MIDDLE AGED; PHOSPHORUS; PHOSPHORUS, DIETARY; PROSTATIC NEOPLASMS; RANDOMIZED CONTROLLED TRIALS; RISK FACTORS; SMOKING; VITAMIN D;

EID: 0033784733     PISSN: 09575243     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1008947201132     Document Type: Article

References (61)

1. Cancer Incidence in Five Continents
2. How is individual risk for prostate cancer assessed?
3. 2 vitamin D and prostate cancer: A hypothesis
4. Geographic patterns of prostate cancer mortality
5. Association of prostate cancer risk with genetic polymorphisms in Vitamin D receptor and androgen receptor
6. Vitamin D and prostate cancer
7. Is vitamin D deficiency a risk factor for prostate cancer? (Hypothesis)
8. 3 receptors and actions in human prostate cancer cell lines
9. 3 on primary cultures of human prostatic cells
10. 3 in androgen-dependent LNCaP cells
11. Control of LNCaP proliferation and differentiation: Actions and interactions of androgens, 1alpha,25-dihydroxycholecalciferol, all-trans retinoic acid, 9-cis retinoic acid, and phenylacetate
12. Vitamin D receptor expression, 24-hydroxylase activity, and inhibition of growth by 1α,25-dihydroxyvitamin D3 in seven human prostatic carcinoma cell lines
13. Inhibition of human prostatic carcinoma cell lines by 1,25-dihydroxyvitamin D3 and vitamin D analogs
14. Vitamin D
15. Intermediary metabolism of fructose
16. Calcitriol metabolism during chronic metabolic acidosis
17. Dietary protein, metabolic acidosis, and calcium balance
18. 2D in phosphorus-restricted normal men
19. Calcium and fructose intake in relation to risk of prostate cancer
20. Dairy products, calcium, phosphorus, vitamin D, and risk of prostate cancer
21. Animal products, calcum, and protein and prostate cancer risk in the Netherlands Cohort Study
22. Dietary factors and risk for prostate cancer among blacks and whites in the United States
23. Dietary beta-carotene and cancer of the prostate: A case-control study in Kyoto, Japan
24. Diet and prostate cancer: A case-control study
25. Vitamin and mineral supplement use is associated with reduced risk of prostate cancer
26. The Alpha-Tocopherol, Beta-Carotene Lung Cancer Prevention Study: Design, methods, participant characteristics, and compliance
27. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers
28. Reproducibility and validity of dietary assessment instruments. I. A self-administered food use questionnaire with a portion size picture booklet
29. Prostate cancer and supplementation with alpha-tocopherol and beta-carotene: Incidence and mortality in a controlled trial
30. Phosphorus
31. Calcium
32. 3 and prostate cancer cell proliferation in vivo
33. Human prostate cancer cells: Inhibition of proliferation by vitamin D analogs
34. Actions of vitamin D3 analogs on human prostate cancer cell lines: Comparison with 1,25-dihydroxyvitamin D3
35. 1α,25-Dihydroxyvitamin D (calcitriol) inhibits the invasiveness of human prostate cancer cells
36. Chemopreventive activity of tamoxifen, N-(4-hydroxyphenyl)retinamide, and the vitamin D analogue Ro24-5531 for androgen-promoted carcinomas of the rat seminal vesicle and prostate
37. Inhibition of prostate cancer metastases in vivo: A comparison of 1,25-dihydroxyvitamin D (calcitriol) and EB 1089
38. Prostate cancer and prediagnostic levels of serum vitamin D metabolites (Maryland, United States)
39. Circulating vitamin D metabolites in relation to subsequent development of prostate cancer
40. Vitamin D and prostate cancer: A prediagnostic study with stored sera
41. Serum vitamin D metabolite levels and the subsequent development of prostate cancer
42. 3 loading and dietary calcium deprivation on plasma 1,25-dihydroxyvitamin D concentrations in healthy adults
43. Endocrine regulation of calcium and phosphate metabolism
44. Diet, nutrition, and prostate cancer
45. Diet and cancer of the prostate: A case-control study in Greece
46. Foods, nutrients and prostate cancer: A case-control study in Uraguay
47. Diet, tobacco use, and fatal prostate cancer: Results from the Lutheran Brotherhood Cohort Study
48. Tobacco use and prostate cancer: 26-Year follow-up of US veterans
49. Cigarette smoking as a predictor of death from prostate cancer in 348,874 men screened for the Multiple Risk Factor Intervention Trial
50. Smoking and risk of total and fatal prostate cancer in United States health professionals
51. Uptake and secretion of carcinogenic chemicals by the dog and rat prostate
52. p53 Protein accumulation and gene mutation in the progression of human prostate carcinoma
53. p53 is mutated in a subset of advanced-stage prostate cancers
54. Small subgroup of aggressive, highly proliferative prostatic carcinomas defined by p53 accumulation
55. p53 Mutations in prostate cancer: Frequent expressed transition mutations
56. Supplemental vitamin E intake and prostate cancer risk in a large cohort of men in the United States